 |
In vitro biological activity detection is a mandatory item for clinical application of biological products, with high requirements for method developm..
|
 |
From a one-stop biopharmaceutical preclinical R&D service platform, to Medicilon Academician Innovative Drug Maturation Center and New Drug Ecological..
|
 |
On December 5, the awarding ceremony for the first batch of Shanghai innovative enterprise headquarters was held. Zheng Gong, Deputy Secretary of the..
|
 |
On November 30, the "Focus on the development of innovative drugs and promote the upgrading of the industrial chain - Medicilon Academician Innovative..
|
 |
Recently, the Class 1 innovative drug ZG-001 developed by Shanghai Zhigen Pharmaceutical Technology Co., Ltd. (Zhigen Pharmaceutical) has received the..
|
 |
On November 20, LF01, an innovative anti-tumor drug independently developed by Longsee Biomedical Co. Ltd. (Longsee Biomedical), received the NMPA dru..
|
 |
Recently, YY201, a STAT3 dual phosphorylation site inhibitor independently developed by Yuyao Biotech, was approved by the US FDA and agreed to conduc..
|
 |
1. What is CDISC
The full name of CDISC is Clinical Data
Interchange Standards Consortium, which is the Clinical Data Interchange
Standards Assoc..
|
 |
For pharmaceutical R&D personnel, the amount of data in pharmaceutical research is very large, and integrating such huge data is a very complicated ..
|
 |
Ensuring data quality and accuracy in non-clinical data exchange requires multi-party collaboration and implementation of measures.
|
|
|
first
prev
Profile
Writing
Friends
Share This